Drugs Similar to RUFINAMIDE
RUFINAMIDE
Related medications based on brand, generic name, substance, active ingredients.
By Brand
Drugs with the same brand name or brand family
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.20. The drug substance is a white crystalline powder. Rufinamide is practically insoluble in water, slightly soluble in tetrahydrofuran and in methanol, and very slightly soluble in ethanol and in acetonitrile. Rufinamide Tablets, USP are available for oral administration containing either 200 mg or 400 mg of rufinamide, USP. Each film-coated tablet contains the following inactive ingredients: croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, Opadry Pink, pregelatinized corn starch and sodium lauryl sulfate. Opadry Pink contains: hypromellose, iron oxide red, propylene glycol, talc and titanium dioxide. chem
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.20. The drug substance is a white crystalline powder. Rufinamide is practically insoluble in water, slightly soluble in tetrahydrofuran and in methanol, and very slightly soluble in ethanol and in acetonitrile. Rufinamide Oral Suspension is available for oral administration as a liquid containing rufinamide, USP at a concentration of 40 mg/mL. Inactive ingredients include: anhydrous citric acid, hydroxyethyl cellulose, methylparaben, microcrystalline cellulose and carboxymethylcellulose sodium, poloxamer, potassium sorbate, propylene glycol, propylparaben, purified water, simethicone emulsion, sodium hydroxide, sorbitol solution and orange flavoring. Chemical Structure
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2, 6-Difluorophenyl)-methyl]-1H-1, 2, 3-triazole-4-carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.19. The drug substance is a white to cream colored powder, hygroscopic. Rufinamide is slightly soluble in dimethyl formamide.. Rufinamide is available for oral administration in film-coated tablets, functionally scored on both sides, containing 200 and 400 mg of rufinamide. Inactive ingredients are colloidal silicon dioxide, crospovidone, hypromellose, iron oxide red, lactose monohydrate, magnesium stearate, polyethylene glycol, polysorbate 80, sodium lauryl sulfate and titanium dioxide. structure
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-Difluorophenyl)methyl]-1H-1,2,3-triazole-4-carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.19. The drug substance is a white, crystalline neutral powder. Rufinamide is slightly soluble in tetrahydrofuran and in methanol, very slightly soluble in alcohol and in acetonitrile, practically insoluble in water. Rufinamide is available for oral administration as a liquid containing rufinamide USP at a concentration of 40 mg/mL. Inactive ingredients include anhydrous citric acid, hydroxyethyl cellulose, methyl paraben, microcrystalline cellulose and carboxymethyl cellulose sodium, orange flavor, poloxamer, potassium sorbate, propylene glycol, propyl paraben, purified water, simethicone emulsion and sorbitol. rufinamideoschemicalstructure
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.20. The drug substance is a white crystalline powder. Rufinamide is practically insoluble in water, slightly soluble in tetrahydrofuran and in methanol, and very slightly soluble in ethanol and in acetonitrile. Rufinamide Oral Suspension is available for oral administration as a liquid containing rufinamide, USP at a concentration of 40 mg/mL. Inactive ingredients include: anhydrous citric acid, hydroxyethyl cellulose, methylparaben, microcrystalline cellulose and carboxymethylcellulose sodium, poloxamer, potassium sorbate, propylene glycol, propylparaben, purified water, simethicone emulsion, sodium hydroxide, sorbitol solution and orange flavoring. Chemical Structure
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-Difluorophenyl)methyl]-1H-1,2,3-triazole-4-carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.19. The drug substance is a white, crystalline neutral powder. Rufinamide is slightly soluble in tetrahydrofuran and in methanol, very slightly soluble in alcohol and in acetonitrile, practically insoluble in water. Rufinamide is available for oral administration as a liquid containing rufinamide USP at a concentration of 40 mg/mL. Inactive ingredients include anhydrous citric acid, hydroxyethyl cellulose, methyl paraben, microcrystalline cellulose and carboxymethyl cellulose sodium, orange flavor, poloxamer, potassium sorbate, propylene glycol, propyl paraben, purified water, simethicone emulsion and sorbitol. rufinamideoschemicalstructure
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has a molecular formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2. The drug substance is a white to off-white crystalline powder. Rufinamide USP is slightly soluble in tetrahydrofuran and in methanol; very slightly soluble in alcohol and in acetonitrile; practically insoluble in water. Rufinamide tablets, USP are available for oral administration in film-coated tablets, scored on both sides, containing 200 mg and 400 mg of rufinamide USP. Inactive ingredients are colloidal silicon dioxide, corn starch, croscarmellose sodium, hypromellose, iron oxide red, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium lauryl sulfate, talc, and titanium dioxide. FDA approved dissolution test specifications differ from USP. str
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.194. The drug substance is a white to off white color powder, crystalline, odorless and slightly bitter tasting neutral powder. Rufinamide is slightly soluble in dimethylsulfoxide, tetrahydrofuran and in methanol, very slightly soluble in alcohol and in acetonitrile, practically insoluble in water. Rufinamide tablet USP is available for oral administration in film-coated tablets, scored on both sides, containing 100 mg, 200 mg and 400 mg of rufinamide. Inactive ingredients are colloidal silicon dioxide, corn starch, croscarmellose sodium, hypromellose, iron oxide red, lactose monohydrate, magnesium stearate, polyethylene glycol, polyvinyl alcohol, sodium lauryl sulphate, talc, titanium dioxide. USP Dissolution Test 2 is used. Rufinamide
Rufinamide, USP is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide, USP has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H- 1,2,3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2 g/mol. The drug substance is a white to off-white crystalline powder. Rufinamide, USP is practically insoluble in water, slightly soluble in tetrahydrofuran and in methanol, and very slightly soluble in ethanol and in acetonitrile. Rufinamide Tablets, USP are available for oral administration as film-coated tablets, scored on both sides, containing either 200 mg or 400 mg of rufinamide, USP. Inactive ingredients are colloidal silicon dioxide, corn starch, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, sodium lauryl sulfate, talc, iron oxide red, polyethylene glycol, and titanium dioxide. Structure
Rufinamide, USP is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide, USP has the chemical name 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-triazole-4 carboxamide. It has a molecular formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2. The drug substance is a white, crystalline powder. Rufinamide, USP is insoluble in water, slightly soluble in tetrahydrofuran and in methanol, and very slightly soluble in alcohol and in acetonitrile. Rufinamide is available for oral administration as a liquid containing rufinamide, USP at a concentration of 40 mg/mL. Inactive ingredients include anhydrous citric acid powder, hydrochloric acid, hydroxyethylcellulose, methylparaben, microcrystalline cellulose & carboxymethylcellulose sodium, natural and artificial orange flavor, poloxamer 188, potassium sorbate, propylene glycol, propylparaben, purified water, simethicone emulsion 30%, sodium hydroxide and sorbitol solution 70%. Structure
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has a molecular formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2. The drug substance is a white to off-white crystalline powder. Rufinamide USP is slightly soluble in tetrahydrofuran and in methanol; very slightly soluble in alcohol and in acetonitrile; practically insoluble in water. Rufinamide is also available for oral administration as a liquid containing rufinamide at a concentration of 40 mg/mL. Inactive ingredients include citric acid anhydrous, hydroxyethylcellulose, methylparaben, microcrystalline cellulose and carboxymethylcellulose sodium, noncrystallizing sorbitol solution, orange flavor (which contains dl-alpha-tocopherols and natural & artificial flavors), poloxamer 188, potassium sorbate, propylene glycol, propylparaben, purified water, and simethicone emulsion. structure
Rufinamide tablet USP is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide USP has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2. The drug substance is a white to off white colour powder. Rufinamide is slightly soluble in tetrahydrofuran and in methanol; very slightly soluble in alcohol and in acetonitrile; practically insoluble in water. Rufinamide tablet USP is available for oral administration in film-coated tablets, scored on both sides, containing 200 and 400 mg of rufinamide. Inactive ingredients are colloidal silicon dioxide, corn starch, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, methocel K 3 Premium LV hydroxypropyl methyl cellulose, microcrystalline cellulose and sodium lauryl sulfate. The film coating contains hypromellose, iron oxide red, polyethylene glycol, talc, and titanium dioxide. structure
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2, 6-difluorophenyl) methyl]-1 H -1, 2, 3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2. The drug substance is a white, crystalline, powder. Rufinamide is practically insoluble in water, slightly soluble in dimethylsulphoxide, tetrahydrofuran and in methanol, and very slightly soluble in ethanol and in acetonitrile. Rufinamide is available for oral administration as a liquid containing rufinamide at a concentration of 40 mg/mL. Inactive ingredients include Citric acid anhydrous, colloidal silicon dioxide , hydroxy ethyl cellulose, methyl paraben, microcrystalline cellulose/ carboxymethyl cellulose sodium, non-crystallizing sorbitol solution, orange juice, poloxamer 188, potassium sorbate, propyl paraben, propylene glycol, simethicone emulsion. description
Rufinamide, USP is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide, USP has the chemical name 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-triazole-4 carboxamide. It has an molecular formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2. The drug substance is a white, crystalline, odorless, and slightly bitter tasting neutral powder. Rufinamide, USP is practically insoluble in water, slightly soluble in tetrahydrofuran and in methanol and soluble in dimethyl sulfoxide. Rufinamide is available for oral administration as a liquid containing rufinamide, USP at a concentration of 40 mg/mL. Inactive ingredients include anhydrous citric acid, colloidal silicon dioxide, microcrystalline cellulose and carboxymethylcellulose sodium, poloxamer 188, methylparaben, non-crystallizing sorbitol solution 70%, propylparaben, propylene glycol, potassium sorbate, orange flavor, triacetin, natural and artificial flavor, simethicone emulsion 30%, and xanthan gum. rufi-suspn-structure
By Generic Name
Drugs with the same generic name (different brands)
BANZEL (rufinamide) is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2. The drug substance is a white, crystalline, odorless, and slightly bitter tasting neutral powder. Rufinamide is practically insoluble in water, slightly soluble in tetrahydrofuran and in methanol, and very slightly soluble in ethanol and in acetonitrile. BANZEL is available for oral administration in film-coated tablets, scored on both sides, containing 200 and 400 mg of rufinamide. Inactive ingredients are colloidal silicon dioxide, corn starch crosscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and sodium lauryl sulphate. The film coating contains hypromellose, iron oxide red, polyethylene glycol, talc, and titanium dioxide. BANZEL is also available for oral administration as a liquid containing rufinamide at a concentration of 40 mg/mL. Inactive ingredients include microcrystalline cellulose and carboxymethylcellulose sodium, hydroxyethylcellulose, anhydrous citric acid, simethicone emulsion 30%, poloxamer 188, methylparaben, propylparaben, propylene glycol, potassium sorbate, noncrystallizing sorbitol solution 70%, and an orange flavor. BANZEL (rufinamide)
Rufinamide tablet USP is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide USP has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2. The drug substance is a white to off white colour powder. Rufinamide is slightly soluble in tetrahydrofuran and in methanol; very slightly soluble in alcohol and in acetonitrile; practically insoluble in water. Rufinamide tablet USP is available for oral administration in film-coated tablets, scored on both sides, containing 200 and 400 mg of rufinamide. Inactive ingredients are colloidal silicon dioxide, corn starch, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, methocel K 3 Premium LV hydroxypropyl methyl cellulose, microcrystalline cellulose and sodium lauryl sulfate. The film coating contains hypromellose, iron oxide red, polyethylene glycol, talc, and titanium dioxide. structure
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has a molecular formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2. The drug substance is a white to off-white crystalline powder. Rufinamide USP is slightly soluble in tetrahydrofuran and in methanol; very slightly soluble in alcohol and in acetonitrile; practically insoluble in water. Rufinamide tablets, USP are available for oral administration in film-coated tablets, scored on both sides, containing 200 mg and 400 mg of rufinamide USP. Inactive ingredients are colloidal silicon dioxide, corn starch, croscarmellose sodium, hypromellose, iron oxide red, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium lauryl sulfate, talc, and titanium dioxide. FDA approved dissolution test specifications differ from USP. str
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.20. The drug substance is a white crystalline powder. Rufinamide is practically insoluble in water, slightly soluble in tetrahydrofuran and in methanol, and very slightly soluble in ethanol and in acetonitrile. Rufinamide Tablets, USP are available for oral administration containing either 200 mg or 400 mg of rufinamide, USP. Each film-coated tablet contains the following inactive ingredients: croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, Opadry Pink, pregelatinized corn starch and sodium lauryl sulfate. Opadry Pink contains: hypromellose, iron oxide red, propylene glycol, talc and titanium dioxide. chem
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.20. The drug substance is a white crystalline powder. Rufinamide is practically insoluble in water, slightly soluble in tetrahydrofuran and in methanol, and very slightly soluble in ethanol and in acetonitrile. Rufinamide Oral Suspension is available for oral administration as a liquid containing rufinamide, USP at a concentration of 40 mg/mL. Inactive ingredients include: anhydrous citric acid, hydroxyethyl cellulose, methylparaben, microcrystalline cellulose and carboxymethylcellulose sodium, poloxamer, potassium sorbate, propylene glycol, propylparaben, purified water, simethicone emulsion, sodium hydroxide, sorbitol solution and orange flavoring. Chemical Structure
Rufinamide, USP is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide, USP has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H- 1,2,3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2 g/mol. The drug substance is a white to off-white crystalline powder. Rufinamide, USP is practically insoluble in water, slightly soluble in tetrahydrofuran and in methanol, and very slightly soluble in ethanol and in acetonitrile. Rufinamide Tablets, USP are available for oral administration as film-coated tablets, scored on both sides, containing either 200 mg or 400 mg of rufinamide, USP. Inactive ingredients are colloidal silicon dioxide, corn starch, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, sodium lauryl sulfate, talc, iron oxide red, polyethylene glycol, and titanium dioxide. Structure
Rufinamide, USP is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide, USP has the chemical name 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-triazole-4 carboxamide. It has a molecular formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2. The drug substance is a white, crystalline powder. Rufinamide, USP is insoluble in water, slightly soluble in tetrahydrofuran and in methanol, and very slightly soluble in alcohol and in acetonitrile. Rufinamide is available for oral administration as a liquid containing rufinamide, USP at a concentration of 40 mg/mL. Inactive ingredients include anhydrous citric acid powder, hydrochloric acid, hydroxyethylcellulose, methylparaben, microcrystalline cellulose & carboxymethylcellulose sodium, natural and artificial orange flavor, poloxamer 188, potassium sorbate, propylene glycol, propylparaben, purified water, simethicone emulsion 30%, sodium hydroxide and sorbitol solution 70%. Structure
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-Difluorophenyl)methyl]-1H-1,2,3-triazole-4-carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.19. The drug substance is a white, crystalline neutral powder. Rufinamide is slightly soluble in tetrahydrofuran and in methanol, very slightly soluble in alcohol and in acetonitrile, practically insoluble in water. Rufinamide is available for oral administration as a liquid containing rufinamide USP at a concentration of 40 mg/mL. Inactive ingredients include anhydrous citric acid, hydroxyethyl cellulose, methyl paraben, microcrystalline cellulose and carboxymethyl cellulose sodium, orange flavor, poloxamer, potassium sorbate, propylene glycol, propyl paraben, purified water, simethicone emulsion and sorbitol. rufinamideoschemicalstructure
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.194. The drug substance is a white to off white color powder, crystalline, odorless and slightly bitter tasting neutral powder. Rufinamide is slightly soluble in dimethylsulfoxide, tetrahydrofuran and in methanol, very slightly soluble in alcohol and in acetonitrile, practically insoluble in water. Rufinamide tablet USP is available for oral administration in film-coated tablets, scored on both sides, containing 100 mg, 200 mg and 400 mg of rufinamide. Inactive ingredients are colloidal silicon dioxide, corn starch, croscarmellose sodium, hypromellose, iron oxide red, lactose monohydrate, magnesium stearate, polyethylene glycol, polyvinyl alcohol, sodium lauryl sulphate, talc, titanium dioxide. USP Dissolution Test 2 is used. Rufinamide
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2, 6-Difluorophenyl)-methyl]-1H-1, 2, 3-triazole-4-carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.19. The drug substance is a white to cream colored powder, hygroscopic. Rufinamide is slightly soluble in dimethyl formamide.. Rufinamide is available for oral administration in film-coated tablets, functionally scored on both sides, containing 200 and 400 mg of rufinamide. Inactive ingredients are colloidal silicon dioxide, crospovidone, hypromellose, iron oxide red, lactose monohydrate, magnesium stearate, polyethylene glycol, polysorbate 80, sodium lauryl sulfate and titanium dioxide. structure
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2, 6-difluorophenyl) methyl]-1 H -1, 2, 3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2. The drug substance is a white, crystalline, powder. Rufinamide is practically insoluble in water, slightly soluble in dimethylsulphoxide, tetrahydrofuran and in methanol, and very slightly soluble in ethanol and in acetonitrile. Rufinamide is available for oral administration as a liquid containing rufinamide at a concentration of 40 mg/mL. Inactive ingredients include Citric acid anhydrous, colloidal silicon dioxide , hydroxy ethyl cellulose, methyl paraben, microcrystalline cellulose/ carboxymethyl cellulose sodium, non-crystallizing sorbitol solution, orange juice, poloxamer 188, potassium sorbate, propyl paraben, propylene glycol, simethicone emulsion. description
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-Difluorophenyl)methyl]-1H-1,2,3-triazole-4-carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.19. The drug substance is a white, crystalline neutral powder. Rufinamide is slightly soluble in tetrahydrofuran and in methanol, very slightly soluble in alcohol and in acetonitrile, practically insoluble in water. Rufinamide is available for oral administration as a liquid containing rufinamide USP at a concentration of 40 mg/mL. Inactive ingredients include anhydrous citric acid, hydroxyethyl cellulose, methyl paraben, microcrystalline cellulose and carboxymethyl cellulose sodium, orange flavor, poloxamer, potassium sorbate, propylene glycol, propyl paraben, purified water, simethicone emulsion and sorbitol. rufinamideoschemicalstructure
Rufinamide, USP is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide, USP has the chemical name 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-triazole-4 carboxamide. It has an molecular formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2. The drug substance is a white, crystalline, odorless, and slightly bitter tasting neutral powder. Rufinamide, USP is practically insoluble in water, slightly soluble in tetrahydrofuran and in methanol and soluble in dimethyl sulfoxide. Rufinamide is available for oral administration as a liquid containing rufinamide, USP at a concentration of 40 mg/mL. Inactive ingredients include anhydrous citric acid, colloidal silicon dioxide, microcrystalline cellulose and carboxymethylcellulose sodium, poloxamer 188, methylparaben, non-crystallizing sorbitol solution 70%, propylparaben, propylene glycol, potassium sorbate, orange flavor, triacetin, natural and artificial flavor, simethicone emulsion 30%, and xanthan gum. rufi-suspn-structure
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.20. The drug substance is a white crystalline powder. Rufinamide is practically insoluble in water, slightly soluble in tetrahydrofuran and in methanol, and very slightly soluble in ethanol and in acetonitrile. Rufinamide Oral Suspension is available for oral administration as a liquid containing rufinamide, USP at a concentration of 40 mg/mL. Inactive ingredients include: anhydrous citric acid, hydroxyethyl cellulose, methylparaben, microcrystalline cellulose and carboxymethylcellulose sodium, poloxamer, potassium sorbate, propylene glycol, propylparaben, purified water, simethicone emulsion, sodium hydroxide, sorbitol solution and orange flavoring. Chemical Structure
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has a molecular formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2. The drug substance is a white to off-white crystalline powder. Rufinamide USP is slightly soluble in tetrahydrofuran and in methanol; very slightly soluble in alcohol and in acetonitrile; practically insoluble in water. Rufinamide is also available for oral administration as a liquid containing rufinamide at a concentration of 40 mg/mL. Inactive ingredients include citric acid anhydrous, hydroxyethylcellulose, methylparaben, microcrystalline cellulose and carboxymethylcellulose sodium, noncrystallizing sorbitol solution, orange flavor (which contains dl-alpha-tocopherols and natural & artificial flavors), poloxamer 188, potassium sorbate, propylene glycol, propylparaben, purified water, and simethicone emulsion. structure
By Substance
Drugs sharing the same substance name
BANZEL (rufinamide) is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2. The drug substance is a white, crystalline, odorless, and slightly bitter tasting neutral powder. Rufinamide is practically insoluble in water, slightly soluble in tetrahydrofuran and in methanol, and very slightly soluble in ethanol and in acetonitrile. BANZEL is available for oral administration in film-coated tablets, scored on both sides, containing 200 and 400 mg of rufinamide. Inactive ingredients are colloidal silicon dioxide, corn starch crosscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and sodium lauryl sulphate. The film coating contains hypromellose, iron oxide red, polyethylene glycol, talc, and titanium dioxide. BANZEL is also available for oral administration as a liquid containing rufinamide at a concentration of 40 mg/mL. Inactive ingredients include microcrystalline cellulose and carboxymethylcellulose sodium, hydroxyethylcellulose, anhydrous citric acid, simethicone emulsion 30%, poloxamer 188, methylparaben, propylparaben, propylene glycol, potassium sorbate, noncrystallizing sorbitol solution 70%, and an orange flavor. BANZEL (rufinamide)
Rufinamide tablet USP is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide USP has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2. The drug substance is a white to off white colour powder. Rufinamide is slightly soluble in tetrahydrofuran and in methanol; very slightly soluble in alcohol and in acetonitrile; practically insoluble in water. Rufinamide tablet USP is available for oral administration in film-coated tablets, scored on both sides, containing 200 and 400 mg of rufinamide. Inactive ingredients are colloidal silicon dioxide, corn starch, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, methocel K 3 Premium LV hydroxypropyl methyl cellulose, microcrystalline cellulose and sodium lauryl sulfate. The film coating contains hypromellose, iron oxide red, polyethylene glycol, talc, and titanium dioxide. structure
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2, 6-difluorophenyl) methyl]-1 H -1, 2, 3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2. The drug substance is a white, crystalline, powder. Rufinamide is practically insoluble in water, slightly soluble in dimethylsulphoxide, tetrahydrofuran and in methanol, and very slightly soluble in ethanol and in acetonitrile. Rufinamide is available for oral administration as a liquid containing rufinamide at a concentration of 40 mg/mL. Inactive ingredients include Citric acid anhydrous, colloidal silicon dioxide , hydroxy ethyl cellulose, methyl paraben, microcrystalline cellulose/ carboxymethyl cellulose sodium, non-crystallizing sorbitol solution, orange juice, poloxamer 188, potassium sorbate, propyl paraben, propylene glycol, simethicone emulsion. description
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-Difluorophenyl)methyl]-1H-1,2,3-triazole-4-carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.19. The drug substance is a white, crystalline neutral powder. Rufinamide is slightly soluble in tetrahydrofuran and in methanol, very slightly soluble in alcohol and in acetonitrile, practically insoluble in water. Rufinamide is available for oral administration as a liquid containing rufinamide USP at a concentration of 40 mg/mL. Inactive ingredients include anhydrous citric acid, hydroxyethyl cellulose, methyl paraben, microcrystalline cellulose and carboxymethyl cellulose sodium, orange flavor, poloxamer, potassium sorbate, propylene glycol, propyl paraben, purified water, simethicone emulsion and sorbitol. rufinamideoschemicalstructure
Rufinamide, USP is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide, USP has the chemical name 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-triazole-4 carboxamide. It has an molecular formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2. The drug substance is a white, crystalline, odorless, and slightly bitter tasting neutral powder. Rufinamide, USP is practically insoluble in water, slightly soluble in tetrahydrofuran and in methanol and soluble in dimethyl sulfoxide. Rufinamide is available for oral administration as a liquid containing rufinamide, USP at a concentration of 40 mg/mL. Inactive ingredients include anhydrous citric acid, colloidal silicon dioxide, microcrystalline cellulose and carboxymethylcellulose sodium, poloxamer 188, methylparaben, non-crystallizing sorbitol solution 70%, propylparaben, propylene glycol, potassium sorbate, orange flavor, triacetin, natural and artificial flavor, simethicone emulsion 30%, and xanthan gum. rufi-suspn-structure
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has a molecular formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2. The drug substance is a white to off-white crystalline powder. Rufinamide USP is slightly soluble in tetrahydrofuran and in methanol; very slightly soluble in alcohol and in acetonitrile; practically insoluble in water. Rufinamide is also available for oral administration as a liquid containing rufinamide at a concentration of 40 mg/mL. Inactive ingredients include citric acid anhydrous, hydroxyethylcellulose, methylparaben, microcrystalline cellulose and carboxymethylcellulose sodium, noncrystallizing sorbitol solution, orange flavor (which contains dl-alpha-tocopherols and natural & artificial flavors), poloxamer 188, potassium sorbate, propylene glycol, propylparaben, purified water, and simethicone emulsion. structure
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.20. The drug substance is a white crystalline powder. Rufinamide is practically insoluble in water, slightly soluble in tetrahydrofuran and in methanol, and very slightly soluble in ethanol and in acetonitrile. Rufinamide Tablets, USP are available for oral administration containing either 200 mg or 400 mg of rufinamide, USP. Each film-coated tablet contains the following inactive ingredients: croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, Opadry Pink, pregelatinized corn starch and sodium lauryl sulfate. Opadry Pink contains: hypromellose, iron oxide red, propylene glycol, talc and titanium dioxide. chem
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.194. The drug substance is a white to off white color powder, crystalline, odorless and slightly bitter tasting neutral powder. Rufinamide is slightly soluble in dimethylsulfoxide, tetrahydrofuran and in methanol, very slightly soluble in alcohol and in acetonitrile, practically insoluble in water. Rufinamide tablet USP is available for oral administration in film-coated tablets, scored on both sides, containing 100 mg, 200 mg and 400 mg of rufinamide. Inactive ingredients are colloidal silicon dioxide, corn starch, croscarmellose sodium, hypromellose, iron oxide red, lactose monohydrate, magnesium stearate, polyethylene glycol, polyvinyl alcohol, sodium lauryl sulphate, talc, titanium dioxide. USP Dissolution Test 2 is used. Rufinamide
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2, 6-Difluorophenyl)-methyl]-1H-1, 2, 3-triazole-4-carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.19. The drug substance is a white to cream colored powder, hygroscopic. Rufinamide is slightly soluble in dimethyl formamide.. Rufinamide is available for oral administration in film-coated tablets, functionally scored on both sides, containing 200 and 400 mg of rufinamide. Inactive ingredients are colloidal silicon dioxide, crospovidone, hypromellose, iron oxide red, lactose monohydrate, magnesium stearate, polyethylene glycol, polysorbate 80, sodium lauryl sulfate and titanium dioxide. structure
Rufinamide, USP is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide, USP has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H- 1,2,3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2 g/mol. The drug substance is a white to off-white crystalline powder. Rufinamide, USP is practically insoluble in water, slightly soluble in tetrahydrofuran and in methanol, and very slightly soluble in ethanol and in acetonitrile. Rufinamide Tablets, USP are available for oral administration as film-coated tablets, scored on both sides, containing either 200 mg or 400 mg of rufinamide, USP. Inactive ingredients are colloidal silicon dioxide, corn starch, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, sodium lauryl sulfate, talc, iron oxide red, polyethylene glycol, and titanium dioxide. Structure
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.20. The drug substance is a white crystalline powder. Rufinamide is practically insoluble in water, slightly soluble in tetrahydrofuran and in methanol, and very slightly soluble in ethanol and in acetonitrile. Rufinamide Oral Suspension is available for oral administration as a liquid containing rufinamide, USP at a concentration of 40 mg/mL. Inactive ingredients include: anhydrous citric acid, hydroxyethyl cellulose, methylparaben, microcrystalline cellulose and carboxymethylcellulose sodium, poloxamer, potassium sorbate, propylene glycol, propylparaben, purified water, simethicone emulsion, sodium hydroxide, sorbitol solution and orange flavoring. Chemical Structure
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.20. The drug substance is a white crystalline powder. Rufinamide is practically insoluble in water, slightly soluble in tetrahydrofuran and in methanol, and very slightly soluble in ethanol and in acetonitrile. Rufinamide Oral Suspension is available for oral administration as a liquid containing rufinamide, USP at a concentration of 40 mg/mL. Inactive ingredients include: anhydrous citric acid, hydroxyethyl cellulose, methylparaben, microcrystalline cellulose and carboxymethylcellulose sodium, poloxamer, potassium sorbate, propylene glycol, propylparaben, purified water, simethicone emulsion, sodium hydroxide, sorbitol solution and orange flavoring. Chemical Structure
Rufinamide, USP is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide, USP has the chemical name 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-triazole-4 carboxamide. It has a molecular formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2. The drug substance is a white, crystalline powder. Rufinamide, USP is insoluble in water, slightly soluble in tetrahydrofuran and in methanol, and very slightly soluble in alcohol and in acetonitrile. Rufinamide is available for oral administration as a liquid containing rufinamide, USP at a concentration of 40 mg/mL. Inactive ingredients include anhydrous citric acid powder, hydrochloric acid, hydroxyethylcellulose, methylparaben, microcrystalline cellulose & carboxymethylcellulose sodium, natural and artificial orange flavor, poloxamer 188, potassium sorbate, propylene glycol, propylparaben, purified water, simethicone emulsion 30%, sodium hydroxide and sorbitol solution 70%. Structure
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-Difluorophenyl)methyl]-1H-1,2,3-triazole-4-carboxamide. It has an empirical formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.19. The drug substance is a white, crystalline neutral powder. Rufinamide is slightly soluble in tetrahydrofuran and in methanol, very slightly soluble in alcohol and in acetonitrile, practically insoluble in water. Rufinamide is available for oral administration as a liquid containing rufinamide USP at a concentration of 40 mg/mL. Inactive ingredients include anhydrous citric acid, hydroxyethyl cellulose, methyl paraben, microcrystalline cellulose and carboxymethyl cellulose sodium, orange flavor, poloxamer, potassium sorbate, propylene glycol, propyl paraben, purified water, simethicone emulsion and sorbitol. rufinamideoschemicalstructure
Rufinamide is a triazole derivative structurally unrelated to currently marketed antiepileptic drugs (AEDs). Rufinamide has the chemical name 1-[(2,6-difluorophenyl)methyl]-1 H -1,2,3-triazole-4 carboxamide. It has a molecular formula of C 10 H 8 F 2 N 4 O and a molecular weight of 238.2. The drug substance is a white to off-white crystalline powder. Rufinamide USP is slightly soluble in tetrahydrofuran and in methanol; very slightly soluble in alcohol and in acetonitrile; practically insoluble in water. Rufinamide tablets, USP are available for oral administration in film-coated tablets, scored on both sides, containing 200 mg and 400 mg of rufinamide USP. Inactive ingredients are colloidal silicon dioxide, corn starch, croscarmellose sodium, hypromellose, iron oxide red, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium lauryl sulfate, talc, and titanium dioxide. FDA approved dissolution test specifications differ from USP. str